Perspective: Patents, post-MedImmune

Earlier this year, the Supreme Court shook the foundations of patent licensing and technology transfer, altering the balance of power between patent holders and their licensees and creating profound implications for the life-sciences industry.

Login

Don’t have an account yet?

Register